U.S. House panel spotlights use of FDA rules to slow generic drugs

WASHINGTON (Reuters) - Republican and Democratic lawmakers on Thursday discussed ways to prevent drugmakers from using rules developed to safeguard patients to instead block the sale of cheaper medicines.